Stay updated on Pembrolizumab for Leukoplakia Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.

Latest updates to the Pembrolizumab for Leukoplakia Clinical Trial page
- Check3 days agoChange DetectedThe study record's update dates were modified. Three new timestamps were added (2026-07-07, 2026-07-09, 2028-08-01) and three older timestamps were removed (2025-07-28, 2025-07-30, 2026-08-01).SummaryDifference0.3%

- Check10 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a new version of the page.SummaryDifference0.1%

- Check17 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2, indicating a newer build of the page template or related site software. This appears to be an internal maintenance update rather than a change to study data or eligibility.SummaryDifference0.1%

- Check32 days agoChange DetectedNew help/navigation sections were added to guide users on joining and contacting for the trial, and the header 'Intervention / Treatment' was reformatted to 'Intervention/Treatment'.SummaryDifference0.5%

- Check39 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating a new release of the page content. This update does not appear to alter the study details presented on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page shows a new revision stamp (v3.5.4) replacing the previous v3.5.3, indicating a backend/software update without altering the study details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Leukoplakia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.